據報美的置業及碧桂園等內房正溝通對接發債註冊意向
《澎湃新聞》報道,包括美的置業(03990.HK)、碧桂園(02007.HK)在內的多家房企正溝通發債註冊意向,其中美的置業的最終配額將高於50億元人民幣(下同),具體額度正待交易商協會及中債增進公司審批結果。
據報,中債信用增進公司已將包括龍湖集團(00960.HK)、新城控股和美的置業在內的開發商列為首批受益於「第二支箭」計劃的發行人,同時同意為三企分別提供200億元、150億元和50億元的配額。
另外,據中國銀行間市場交易商協會11月10日消息,龍湖集團的200億元儲架式註冊發行已獲受理,中債增進公司同步受理企業增信業務意向。
碧桂園今日最高見2.32元。現報2.13元,升28.31%,成交12.27億股,涉資24.96億元。
美的置業高見7.99元。現報7.72元,升15.22%,成交1,207.66萬股,涉資9,131.49萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.